Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether NPC-08 is safety and efficacy in the
treatment of newly-diagnosed malignant glioma and recurrent glioblastoma multiforme.